RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. (Q40474790)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

title

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

main subject

RNA interference

1 reference

based on heuristic

inferred from title

neoplastic invasiveness

1 reference

based on heuristic

inferred from title

author

Alexander Steinle

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

Michael Weller

series ordinal

7

object named as

Michael Weller

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

Wolfgang Wick

series ordinal

3

object named as

Wolfgang Wick

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

Jörg Wischhusen

series ordinal

2

object named as

Jörg Wischhusen

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

author name string

Manuel A Friese

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

Markus Weiler

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

Günter Eisele

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

published in

Cancer Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

volume

64

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

issue

20

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

page(s)

7596-7603

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

Identifiers

DOI

10.1158/0008-5472.CAN-04-1627

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

PubMed publication ID

15492287

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15492287

retrieved

20 September 2017

ResearchGate publication ID

8225303

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40474790&oldid=1757505739"